NCT02143869View on ClinicalTrials.gov

Evolution of Corporeal Composition in the PeriOperative Period

CompletedOBSERVATIONAL
Enrollment

374

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

September 30, 2019

Conditions
Gastrointestinal Cancer (Esophagus, Gastric, Pancreatic, Hepatic, Colorectal and Anal)Lung Cancer
Interventions
DEVICE

Bioelectrical Impedance Analysis

Measurements of body composition including fat mass, lean body mass, muscular mass, mineral mass, total body water, intra and extracellular water.

Trial Locations (1)

Unknown

Hôpital Européen Marseille, Marseille

All Listed Sponsors
lead

Hôpital Européen Marseille

OTHER

NCT02143869 - Evolution of Corporeal Composition in the PeriOperative Period | Biotech Hunter | Biotech Hunter